Literature DB >> 9231019

Granular cell tumour of the spinal cord in a patient with Rubenstein-Taybi syndrome.

B J Burton1, V G Kumar, R Bradford.   

Abstract

A case of cervical spinal cord granular cell tumour in a patient with Rubenstein-Taybi syndrome is described. A granular cell tumour arising from the spinal cord itself has never been previously described. Complete excision of the tumour could not be achieved owing to its location. It subsequently recurred and was treated with radiotherapy. The patient made a complete recovery with no further recurrence after 2 years of follow-up.

Entities:  

Mesh:

Year:  1997        PMID: 9231019     DOI: 10.1080/02688699746375

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  6 in total

1.  Granular cell tumors of the spinal canal: intramedullary case report and a review of the literature.

Authors:  Kilian G M Brown; Prashanth J Rao; Than-Htike Oo; Adam Fowler
Journal:  J Spine Surg       Date:  2015-12

2.  Intramedullary astrocytoma with granular cell differentiation.

Authors:  R Rodriguez y Baena; A Di Ieva; P Colombo; P Collini; P Navarria; M Scorsetti; P Gaetani; A Santoro
Journal:  Neurosurg Rev       Date:  2007-05-05       Impact factor: 3.042

Review 3.  Familial syndromes associated with intracranial tumours: a review.

Authors:  Adrianna M Ranger; Yatri K Patel; Navjot Chaudhary; Ram V Anantha
Journal:  Childs Nerv Syst       Date:  2013-11-06       Impact factor: 1.475

4.  Recurrent granular cell tumor: a case report and review of literature.

Authors:  Aditendraditya Singh Bhati; Aarjun Tyagi; Sudheer K Tyagi
Journal:  J Spine Surg       Date:  2017-09

5.  Intradural spinal granular cell tumor.

Authors:  Viren L Vaghasiya; Jitendra G Nasit; Pinki A Parikh; Priti P Trivedi
Journal:  Asian J Neurosurg       Date:  2014-04

6.  Benign and malignant tumors in Rubinstein-Taybi syndrome.

Authors:  Max V Boot; Martine J van Belzen; Lucy I Overbeek; Nathalie Hijmering; Matias Mendeville; Quinten Waisfisz; Pieter Wesseling; Raoul C Hennekam; Daphne de Jong
Journal:  Am J Med Genet A       Date:  2018-01-23       Impact factor: 2.802

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.